Immuno-Oncology

Immune cells have the capability to eliminate tumor cells; however, tumor cells can develop the ability to evade immune responses. Current research efforts have been focused on developing personalized strategies for cancer treatment and developing new therapies that bolster the immune response in the fight against tumor cells.

Below is a collection of scientific resources for your immuno-oncology research.

Sofie Pattijn
Sofie Pattijn, Co-Founder and Chief Technology Officer, ImmunXperts, Belgium
  • Assay Development
  • Immuno-Oncology Drug Development
Bhushan Dharmadhikari, PhD
Bhushan Dharmadhikari, Ph.D., Research Scholar, National University of Singapore Yong Loo Lin School of Medicine
  • Dendritic cell therapy for cancer
  • CD137 (4-1BB) immunotherapy
Steevenson Nelson, PhD
Steevenson Nelson, Ph.D., Management Intern, National Institutes of Health
  • Epigenetic landscape of B cells
  • Use of genome editing on immune cells for clinical applications
Sara McKee, PhD
Sara McKee, Ph.D., Postdoctoral Fellow, University of Queensland
  • Monoclonal antibody therapy for cancer
  • Myeloid-derived suppressor cells

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.